SCOPUS 정보 검색 플랫폼 - 논문 보기

메뉴 건너뛰기

Frontiers in Pediatrics

Volumn 3, Issue , 2015, Pages

Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients

(4) Siehr, Stephanie L a McCarthy, Elisa K a Ogawa, Michelle T a Feinstein, Jeffrey A a

a STANFORD UNIVERSITY (United States)

Author keywords

pediatric pulmonary hypertension; pediatrics; pulmonary hypertension; side effects; sildenafil

Indexed keywords

EID: 84940895521 PISSN: None EISSN: 22962360 Source Type: Journal
DOI: 10.3389/fped.2015.00012 Document Type: Article

Times cited : (20)

References (9)

1
- 26444534291
- Sildenafil citrate therapy for pulmonary arterial hypertension
- 16291984
- Galiè N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med (2005) 353:2148–57.10.1056/NEJMoa05001016291984
- (2005) N Engl J Med , vol.353 , pp. 2148-2157
- Galiè, N.¹ Ghofrani, H.A.² Torbicki, A.³ Barst, R.J.⁴ Rubin, L.J.⁵ Badesch, D.⁶

2
- 80052088060
- Long-term treatment with sildenafil citrate in pulmonary arterial hypertension. the SUPER-2 study
- 21546436
- Rubin LJ, Badesch DB, Fleming TR, Galiè N, Simonneau G, Ghofrani HA, et al. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension. the SUPER-2 study. Chest (2011) 140(5):1274–83.10.1378/chest.10-096921546436
- (2011) Chest , vol.140 , Issue.5 , pp. 1274-1283
- Rubin, L.J.¹ Badesch, D.B.² Fleming, T.R.³ Galiè, N.⁴ Simonneau, G.⁵ Ghofrani, H.A.⁶

3
- 54549125950
- Addition of sildenafil to long-term intravenous epoprostenol in patients with pulmonary arterial hypertension
- 18936500
- Simonneau G, Rubin LJ, Galiè N, Barst RJ, Fleming TR, Frost AE, et al. Addition of sildenafil to long-term intravenous epoprostenol in patients with pulmonary arterial hypertension. Ann Intern Med (2008) 149:521–30.10.7326/0003-4819-149-8-200810210-0000418936500
- (2008) Ann Intern Med , vol.149 , pp. 521-530
- Simonneau, G.¹ Rubin, L.J.² Galiè, N.³ Barst, R.J.⁴ Fleming, T.R.⁵ Frost, A.E.⁶

4
- 84885388217
- Food and drug administration (FDA) postmarket reported side effects and adverse events associated with pulmonary hypertension therapy in pediatric patients
- 23532466
- Maxey DM, Ivy DD, Ogawa MT, Feinstein JA. Food and drug administration (FDA) postmarket reported side effects and adverse events associated with pulmonary hypertension therapy in pediatric patients. Pediatr Cardiol (2013) 34:1628–36.10.1007/s00246-013-0688-223532466
- (2013) Pediatr Cardiol , vol.34 , pp. 1628-1636
- Maxey, D.M.¹ Ivy, D.D.² Ogawa, M.T.³ Feinstein, J.A.⁴

5
- 84875156577
- Implications of the U.S. food and drug administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension
- 23220921
- Abman SH, Kinsella JP, Rosenzweig EB. Implications of the U.S. food and drug administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension. Am J Respir Crit Care Med (2013) 187(6):575–575.10.1164/rccm.201210-1928PP23220921
- (2013) Am J Respir Crit Care Med , vol.187 , Issue.6 , pp. 575
- Abman, S.H.¹ Kinsella, J.P.² Rosenzweig, E.B.³

6
- 78650691642
- Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy
- Buckley MS, Staib RL, Wicks LM, Feldman JP. Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy. Drug Healthc Patient Saf (2010) 2:151–61.10.2147/DHPS.S6215
- (2010) Drug Healthc Patient Saf , vol.2 , pp. 151-161
- Buckley, M.S.¹ Staib, R.L.² Wicks, L.M.³ Feldman, J.P.⁴

7
- 21044449937
- Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study
- 15956137
- Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study. Circulation (2005) 111:3274–80.10.1161/CIRCULATIONAHA.104.47337115956137
- (2005) Circulation , vol.111 , pp. 3274-3280
- Humpl, T.¹ Reyes, J.T.² Holtby, H.³ Stephens, D.⁴ Adatia, I.⁵

8
- 84856106514
- A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naïve children with pulmonary arterial hypertension
- 22128226
- Barst RJ, Ivy DD, Gaitan G, Szatmari A, Rudzinski A, Garcia AE, et al. A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naïve children with pulmonary arterial hypertension. Circulation (2012) 125:324–34.10.1161/CIRCULATIONAHA.110.01666722128226
- (2012) Circulation , vol.125 , pp. 324-334
- Barst, R.J.¹ Ivy, D.D.² Gaitan, G.³ Szatmari, A.⁴ Rudzinski, A.⁵ Garcia, A.E.⁶

9
- 84901505754
- Long-term survival with oral sildenafil monotherapy in treatment-naïve pediatric pulmonary arterial hypertension
- 24637559
- Barst RJ, Beghetti M, Pulido T, Layton G, Konourina I, Zhang M, et al. Long-term survival with oral sildenafil monotherapy in treatment-naïve pediatric pulmonary arterial hypertension. Circulation (2014) 129:1914–23.10.1161/CIRCULATIONAHA.113.00569824637559
- (2014) Circulation , vol.129 , pp. 1914-1923
- Barst, R.J.¹ Beghetti, M.² Pulido, T.³ Layton, G.⁴ Konourina, I.⁵ Zhang, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.